Skip to main content
Livermore
Livermore
ZHEN

Marks Group Wealth Management, Inc

SEC CIK
0001802473
Latest filing
Jul 27, 2026

ABT holding history

Abbott Laboratories in every 13F filed by Marks Group Wealth Management, Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABT overviewAll 13F holders of ABTFull Q2 2026 holdings

Shares (Q2 2026)
12,200
Value
$1.11M
% of portfolio
0.1%
Quarters held
22
Since Q1 2021
Holdings of ABT by Marks Group Wealth Management, Inc, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202612,200$1.11M0.1%+405+3.4%AddedHolders
Q1 202611,795$1.21M0.1%−11,969−50.4%ReducedHolders
Q4 202523,764$2.98M0.3%+15,741+196.2%AddedHolders
Q3 20258,023$1.07M0.1%+42+0.5%AddedHolders
Q2 20257,981$1.09M0.1%−123−1.5%ReducedHolders
Q1 20258,104$1.07M0.1%+272+3.5%AddedHolders
Q4 20247,832$885.9K0.1%00.0%UnchangedHolders
Q3 20247,832$892.9K0.1%−64−0.8%ReducedHolders
Q2 20247,896$820.5K0.1%−115−1.4%ReducedHolders
Q1 20248,011$910.5K0.1%−717−8.2%ReducedHolders
Q4 20238,728$960.7K0.1%+42+0.5%AddedHolders
Q3 20238,686$841.2K0.1%−367−4.1%ReducedHolders
Q2 20239,053$986.9K0.1%−56,460−86.2%ReducedHolders
Q1 202365,513$6.63M0.8%+3,537+5.7%AddedHolders
Q4 202261,976$6.80M0.9%+693+1.1%AddedHolders
Q3 202261,283$5.93M0.9%+1,622+2.7%AddedHolders
Q2 202259,661$6.48M0.9%+3,599+6.4%AddedHolders
Q1 202256,062$6.63M0.8%+4,030+7.7%AddedHolders
Q4 202152,032$7.32M0.9%−1,041−2.0%ReducedHolders
Q3 202153,073$6.28M0.8%+688+1.3%AddedHolders
Q2 202152,385$6.08M0.8%+3,115+6.3%AddedHolders
Q1 202149,270$5.91M0.9%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.